股票市场 | 阿斯利康跌9%，WAINUA试验未达预期
2026-07-09 07:13:31
据金十数据报道，欧股阿斯利康下跌9%，此前其治疗神经系统疾病的药物WAINUA晚期临床试验未达预期。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
国债期货午盘收跌，30年期主力跌0.04%Next article：
男子称富国银行账户遭盗转9888美元
